100
Participants
Start Date
January 23, 2019
Primary Completion Date
January 15, 2020
Study Completion Date
December 15, 2020
Fasinumab AI
Self-administered with auto injector
Fasinumab PFS
Prefilled syringe administered by study staff
Regeneron Research Facility, Jamaica
Regeneron Research Facility, Wilmington
Regeneron Research Facility, Statesville
Regeneron Research Facility, Atlanta
Regeneron Research Facility, Port Orange
Regeneron Research Facility, Orlando
Regeneron Research Facility, Pinellas Park
Regeneron Research Facility, Ocala
Regeneron Research Facility, Bristol
Regeneron Research Facility, Knoxville
Regeneron Research Facility, Lexington
Regeneron Research Facility, Lexington
Regeneron Research Facility, West Des Moines
Regeneron Research Facility, Wichita
Regeneron Research Facility, Oklahoma City
Regeneron Research Facility, Dallas
Regeneron Research Facility, Houston
Regeneron Research Facility, Houston
Regeneron Research Facility, Houston
Regeneron Research Facility, Wheat Ridge
Regeneron Research Facility, Gilbert
Regeneron Research Facility, Glendale
Regeneron Research Facility, Los Angeles
Teva Pharmaceutical Industries, Ltd.
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY